of the tumor types with at least ten samples tested against ifn-alpha a , the percentage of cases exhibiting inhibition was as follows : melanoma ( 51.7 % ) , lung cancer ( 50 % ) , myeloma ( 33.4 % ) , ovarian cancer ( 33.9 % ) , sarcoma ( 33.3 % ) , adenocarcinoma of unknown primary ( 30.4 % ) , breast cancer ( 28 % ) , acute leukemia ( 30.8 % ) , and renal cancer ( 23 % ) .
C2981607
tumor types
C0025202
melanoma